A new type of microglia gene targeting shows TAK1 to be pivotal in CNS autoimmune inflammation - PubMed (original) (raw)

. 2013 Nov;16(11):1618-26.

doi: 10.1038/nn.3531. Epub 2013 Sep 29.

Peter Wieghofer, Philippe F Müller, Yochai Wolf, Diana Varol, Simon Yona, Stefanie M Brendecke, Katrin Kierdorf, Ori Staszewski, Moumita Datta, Tom Luedde, Mathias Heikenwalder, Steffen Jung, Marco Prinz

Affiliations

A new type of microglia gene targeting shows TAK1 to be pivotal in CNS autoimmune inflammation

Tobias Goldmann et al. Nat Neurosci. 2013 Nov.

Abstract

Microglia are brain macrophages and, as such, key immune-competent cells that can respond to environmental changes. Understanding the mechanisms of microglia-specific responses during pathologies is hence vital for reducing disease burden. The definition of microglial functions has so far been hampered by the lack of genetic in vivo approaches that allow discrimination of microglia from closely related peripheral macrophage populations in the body. Here we introduce a mouse experimental system that specifically targets microglia to examine the role of a mitogen-associated protein kinase kinase kinase (MAP3K), transforming growth factor (TGF)-β-activated kinase 1 (TAK1), during autoimmune inflammation. Conditional depletion of TAK1 in microglia only, not in neuroectodermal cells, suppressed disease, significantly reduced CNS inflammation and diminished axonal and myelin damage by cell-autonomous inhibition of the NF-κB, JNK and ERK1/2 pathways. Thus, we found TAK1 to be pivotal in CNS autoimmunity, and we present a tool for future investigations of microglial function in the CNS.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Glia. 2011 Feb;59(2):177-87 - PubMed
    1. Cancer Cell. 2012 Jul 10;22(1):91-105 - PubMed
    1. Neuropharmacology. 2013 Apr;67:78-87 - PubMed
    1. J Exp Med. 2008 Jul 7;205(7):1611-9 - PubMed
    1. Nat Neurosci. 2011 Dec 04;15(1):98-106 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources